PHLDA3 and liver disorder: Hepatic expression levels of PHLDA3 were elevated in patients with liver diseases (e.g., HCV-infected hepatitis, HBV-associated acute liver failure, and liver fibrosis), which was validated in mice models with liver injury [73].